Synthesis & size selection
Develop AuNP preparations and select particle dimensions around colour, stability and assay requirements.
Radetec develops colloidal gold nanoparticles and AuNP conjugates for lateral flow, immunoassay and other bioanalytical research. We connect particle size, surface chemistry and biomolecule loading to the signal and stability the final workflow requires.

Gold nanoparticles produce a strong visible colour and are widely used as labels in lateral flow tests. Useful performance, however, depends on more than the particle itself: size distribution, colloidal stability, surface coverage, binder activity, conjugate release and sample matrix all influence the final signal.
We develop the nanoparticle and conjugation conditions with the downstream assay in view, then evaluate the conjugate under relevant buffer and membrane conditions.
Projects can begin with custom synthesis, an existing particle, an antibody pair or a lateral flow assay that needs a more reliable label.
Develop AuNP preparations and select particle dimensions around colour, stability and assay requirements.
Evaluate pH, buffers, coatings and blocking conditions that influence colloidal behaviour and non-specific interactions.
Optimise passive adsorption or suitable covalent strategies for antibodies and other recognition molecules.
Assess conjugate release, test-line signal, background and compatibility with the intended sample workflow.
Particle concentration and antibody loading are useful starting variables, but they do not define a successful conjugate on their own. We assess retained binding activity, aggregation risk, storage behaviour and performance in the final detection format.
Yes. We can scope gold nanoparticle synthesis and size selection around the intended optical signal, surface chemistry and assay workflow.
Yes. A project can evaluate antibody loading, coupling conditions, blocking and retained recognition activity before integration into the assay.
Yes. Gold nanoparticle development can be combined with membrane, buffer, capture-line and sample-flow optimisation through our lateral flow assay development service.
Yes. We can investigate aggregation, weak signal, high background, poor release and batch inconsistency against an agreed baseline.
Share your target, binder, sample matrix, preferred particle size and intended assay. We can define a focused synthesis, conjugation or assay-integration study.
Discuss your AuNP project